The MTEC Commercialization Program provides outreach, education, mentoring, commercialization and investment support to MTEC members. We are building our M-Corps network of subject matter experts and service providers to help you find the assistance needed to address the business, technical, and regulatory challenges associated with medical product development.
M-Corps offers members a wide variety of support services, including but not limited to:
- – Business development
- – Business and investment planning
- – Cybersecurity
- – Finance
- – Intellectual asset management
- – Legal
- – Logistics/procurement
- – Pitch deck coaching
- – Transaction Advisory
- – CMC
- – Clinical trials
- – Concepts and requirements development
- – Design Development
- – Design Verification
- – Manufacturing
- – Process validation, manufacturing transfer Quality Management (QA/QC)
- – Regulatory Affairs
- – MTEC member in good standing
- – Demonstrated proficiency in service area of expertise
- – Point of contact who will be responsive to MTEC Commercialization Program requests
- – Knowledge of military medical needs or experience working with military technology
- – No unaddressed negative experience reports on services provided, by Members accessing your services
Interested in joining the M-Corp?
Partners must be members in good standing and sign our teaming agreement. Contact Rick Satcher, Director Of Commercialization for more details.
Our network is growing!
M-Corps members include:
Capital Edge federal contract consultants combine their unique backgrounds and experience in consulting, public accounting, industry, and DCAA/DCMA to provide you with unmatched government contracting expertise. This breadth of specialized experience enables us to provide the exact services and level of expertise you need to succeed. They’ve worked with government contractors ranging in size from startup to Fortune 100 companies in industries such as manufacturing, nuclear energy, professional services, biotech/pharmaceuticals, defense, and software. These companies work with a vast array of federal agencies.
The Conafay Group represents life sciences companies, universities, and other organizations in the biomedical space before the federal government and associated stakeholders. They have an in-depth understanding of the federal funding landscape, healthcare and innovation policy, federal government priorities, coalition development, and commercial/institutional partnering opportunities.
ECHELON Med Tech develops and commercializes medical technologies to improve health outcomes for warfighters, veterans and civilians. They partner with leading innovators in medical device research to create dual-use solutions for major health problems, then de-risk and accelerate those innovations for commercial readiness, for strategic partnering, acquisition, and contracting with the military.
Grant Engine helps companies compose and win grants and contracts. Their approach was born from a successful pedigree of building life science and other companies. A key part of that is securing crucial funding in companies changing their fields. At our heart, they are company builders and see non-dilutive funding as an important component to building companies.
Greenlight Guru is the only dedicated Medical Device Success Platform (MDSP) designed specifically for medical device companies. The platform helps companies bring safer products to market faster, simplifies FDA and ISO regulatory compliance and provides a single source of truth by connecting the management of all quality processes like CAPAs, risk, audits and more. Greenlight Guru’s platform is used by thousands of organizations across the globe to push beyond baseline compliance and achieve True Quality for their medical devices.
ICS combines intuitive user experience (UX) design and world-class software development expertise with full product realization services for mission-critical, regulated and tech-centric markets.
McAllister and Quinn provides federal grant consulting and government relations, including strategic intelligence and appropriations tracking, grants strategy and proposal writing, capacity building and training, and federal agency and foundation engagement.
Proxima’s team of experts have all the experience in clinical research management, operations, and regulatory affairs necessary to successfully execute your medical device or drug clinical trial.
SmartHealth Catalyzer accelerates the commercialization of therapeutics, diagnostics and medical devices being developed at Midwest universities and research hospitals that diagnose, prevent and treat life threatening diseases. Located at the epicenter of the largest biomedical cluster in the Midwest, SmartHealth builds biotech startups comprised of elite bioentrepreneurs and biotech experts each with 30+ years industry experience and expertise across drug, diagnostic and med device.
SMI supports companies, universities, and academic institutes secure federal funding for research and development, and technology procurement. Our team is comprised of technical and policy experts, lobbyists, and former executive branch decision-makers who work with our clients to capture non-dilutive federal funds. We guide our clients from technology development through acquisition by the federal government.
Spectrum Group provides healthcare consulting and program management solutions, organizational development, public relations and communications support, public policy development, and government affairs liaising and advocacy. SPECTRUM Cyber Compliance (SCC) delivers integrated security services spanning cyber security, information technology (IT) security, and physical security.
TreMonti Consulting, LLC (TreMonti) has extensive experience in providing advice and assistance to universities, governments and companies regarding intellectual asset management issues. They have fully dedicated professionals with broad experience and in-depth knowledge in all sectors and disciplines relating to intellectual asset management. TreMonti utilizes state-of-the-art tools and methods in the management and commercialization of a wide spectrum of intellectual property.
Xomix designs and implements effective biotechnology initiatives in business, workforce, and economic development. CEO Gary Keller has life sciences industry expertise encompassing scientific, public-private, not-for profit, and business perspectives. Xomix has extensive experience in technology evaluation, technology transfer, development, licensing, and commercialization.
Points of contact are available on the members only website.